00:00Global pharmaceutical company AstraZeneca plans to invest US$50 billion in the U.S. by 2030
00:07to expand drug manufacturing and research.
00:10It is the latest move by a pharmaceutical company
00:13in response to President Donald Trump's proposed tariffs on drug imports.
00:19The investment will include a new drug facility in Virginia
00:22and expanded R&D as well as cell therapy sites in Maryland, Massachusetts, California, Indiana and Texas.
00:30The company also planned to enhance its U.S. clinical trial supply network
00:34and support development of new medicines.
00:36AstraZeneca said the expansion supports its goal of reaching US$80 billion in annual revenue by 2030,
00:43half of which are from the U.S.
00:45The pledge came on top of the US$3.5 billion investment the company announced in November 2024.
00:52The British-Swedish company is known for co-developing one of the first widely used COVID-19 vaccines.
00:58The move to scale up its U.S. presence is the latest by a drugmaker
01:02as Trump threatens to impose import tariffs as it seeks to boost domestic manufacturing.
01:07half of which they are the two
01:11to the next place
01:14and take typically
01:17and the growing
01:19results
01:19to continue
01:23September 2,
01:25June 26th
01:26September 27th
01:28September 27th
01:29September 27th
01:30September 29th
01:30September 28th
01:31September 23rd
01:32September 23rd
01:33September 27th
01:33September 29th
01:34September 29th
01:34September 22nd
01:36September 28th
